A participant from the Pennington Biomedical Research Center site is the 2,000th participant enrolled in D2d. The participant completed the study.

A participant from the Northwestern University site is the 1,500th participant enrolled in D2d. The participant completed the study.

The annual meeting of the D2d research team is held in Arlington, VA. On Sunday evening, principal investigator Dr. Pittas presents the State of D2d, which remains strong. The meeting reinforces the importance of participant recruitment and emphasizes the...

A participant from the MedStar Community Clinical Research Center D2d site is the 1,000th participant enrolled in D2d. The participant completed the study.    

The D2d Data and Safety Monitoring Board (DSMB) meets twice a year to review the study’s progress. At this meeting, the DSMB is impressed with the improvement in recruitment and is pleased with enrollment metrics. The secret to the...

The annual meeting of the D2d research team is held in Crystal City, MD. On Sunday evening, principal investigator Dr. Pittas presents the State of D2d. The meeting focuses on participant recruitment and retention. Site staff share their experience...

The D2d team publishes its first manuscript related to D2d: The rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial. The manuscript is published in Diabetes Care.

A participant at the Atlanta VA Medical Center site is the 500th participant enrolled in D2d. The participant completed the study.

A patient at the University of Kansas site is the 1st participant enrolled in D2d. The participant is still in D2d.

Tufts Medical Center (where the D2d Coordinating Center is based) and NIDDK coordinate a press release to announce the official start of D2d activities.